-
Article
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy
The aim of this study was to analyze the safety, treatment characteristics and survival outcomes of Yttrium-90 (Y90) radioembolization for unresectable colorectal carcinoma (CRC) liver metastases refractory to...
-
Article
Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study
We examined the health-related quality of life (HRQOL) and pain experiences of patients with hepatocellular carcinoma (HCC) and assessed content validity of existing patient-reported pain items for patients wi...
-
Article
PR-104 plus sorafenib in patients with advanced hepatocellular carcinoma
PR-104 is activated by reductases under hypoxia or by aldo–keto reductase 1C3 (AKR1C3) to form cytotoxic nitrogen mustards. Hepatocellular carcinoma (HCC) displays extensive hypoxia and expresses AKR1C3. This ...
-
Article
Erratum to: Curative Approach for Stage IV Colorectal Cancer with Multiorgan Involvement: What Makes Sense and What Doesn’t?
-
Article
Curative Approach for Stage IV Colorectal Cancer with Multiorgan Involvement: What Makes Sense and What Doesn’t?
In 2009, there were almost 150,000 cases of colorectal cancer in the United States. Surgical resection of isolated metastatic pulmonary and hepatic disease has demonstrated a 10-year overall survival rate appr...
-
Article
Internal radioembolization for colorectal carcinoma liver metastases
Colorectal cancer remains a significant cause of morbidity and mortality. Treatment options and therapeutic interventions for patients who have disease progression despite treatment with systemic therapies hav...